ArticleClinical and experimental hepatology2020

Pemafibrate decreases markers of hepatic inflammation in patients with non-alcoholic fatty liver disease.

Satoshi Shinozaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.